Evidence map›Paper›PMID 30042965›Full record

ArticleTomography (Ann Arbor, Mich.)2016

[

Matthew J Oborski, Charles M Laymon, Frank S Lieberman, Yongxian Qian, Jan Drappatz, James M Mountz

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Augmentation of [EJNMMI research · 2025
    Article
  2. Review
  3. Review
  4. Interest and Limits of [Frontiers in oncology · 2021
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew J OborskiDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.
Charles M LaymonDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania.
Frank S LiebermanDepartment of Neurology and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and.
Yongxian QianMR Research Center, Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jan DrappatzDepartment of Neurology and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and.
James M MountzPET Center, Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
NCI NIH HHS P30 CA047904
6 · The paper itself

Abstract

The ability to assess tumor apoptotic response to therapy could provide a direct and prompt measure of therapeutic efficacy.

Indexed as

[18F]ML-10early-therapy assessmentGBMimaging biomarker

Identifiers

PMID30042965
PMCPMC6037921
OpenAlexW2588117499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.